Indomo is a clinical stage therapeutics company in the process of revolutionizing inflammatory acne treatment with the development of an at-home intradermal auto-injector. To accelerate iteration of Indomo’s injectors and reduce human and animal testing, the Indomo skin analog team has designed a novel skin analog that replicates the mechanical and absorption properties of human skin. In parallel, the team has characterized target biological tissues and developed measurement systems to output depth of needle puncture and volume of fluid absorbed.